TipRanks
Advertisement
Advertisement
ValiRx Ends Stingray Evaluation as It Refocuses on Later-Stage Assets
PremiumCompany AnnouncementsValiRx Ends Stingray Evaluation as It Refocuses on Later-Stage Assets
4M ago
ValiRx fast-tracks RNA helicase deal with McGill and plans Canadian spin-out
Premium
Company Announcements
ValiRx fast-tracks RNA helicase deal with McGill and plans Canadian spin-out
4M ago
ValiRx Bolsters Cytolytix IP with New European Patent and Oncolytic Platform Filings
Premium
Company Announcements
ValiRx Bolsters Cytolytix IP with New European Patent and Oncolytic Platform Filings
4M ago
ValiRx trims costs and expands oncology pipeline with new human and veterinary initiatives
PremiumCompany AnnouncementsValiRx trims costs and expands oncology pipeline with new human and veterinary initiatives
6M ago
ValiRx gains oncology spotlight with digital twin data and expanding scientific footprint
Premium
Company Announcements
ValiRx gains oncology spotlight with digital twin data and expanding scientific footprint
6M ago
ValiRx CEO Increases Stake with 1 Million-Share Purchase
Premium
Company Announcements
ValiRx CEO Increases Stake with 1 Million-Share Purchase
7M ago
ValiRx Advances with New Equity and Warrant Issuance Post-General Meeting
PremiumCompany AnnouncementsValiRx Advances with New Equity and Warrant Issuance Post-General Meeting
11M ago
ValiRx PLC Announces Fundraising to Boost Cancer and Women’s Health Research
Premium
Company Announcements
ValiRx PLC Announces Fundraising to Boost Cancer and Women’s Health Research
11M ago
ValiRx PLC Raises £902,000 Through Successful Fundraising
Premium
Company Announcements
ValiRx PLC Raises £902,000 Through Successful Fundraising
11M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―